News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
216 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17551)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
2 (186)
3 (175)
4 (147)
5 (166)
6 (119)
9 (121)
10 (183)
11 (172)
12 (142)
13 (112)
14 (38)
15 (1)
16 (171)
17 (154)
18 (148)
19 (149)
20 (92)
21 (2)
23 (153)
24 (148)
25 (216)
26 (204)
27 (119)
28 (2)
29 (9)
30 (193)
31 (218)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
27
28
29
30
31
Business
Exactech Cancels Q3 Earnings Call Previously Scheduled for Tuesday, October 31, 2017
Exactech announced today that, due to its definitive agreement with TPG Capital to go private, the company will not hold the Third Quarter conference call previously scheduled for Tuesday, October 31, 2017.
October 25, 2017
·
2 min read
Deals
Endo Completes Divestiture of Grupo Farmaceutico SOMAR
Endo International today announced the completion of the previously announced sale of Grupo Farmaceutico SOMAR to Advent International for a purchase price of approximately $124M.
October 25, 2017
·
2 min read
Business
Vertex Reports Third-Quarter 2017 Financial Results
Vertex Pharmaceuticals Incorporated today reported consolidated financial results for the third quarter ended September 30, 2017.
October 25, 2017
·
30 min read
Business
Novoheart Holdings Inc. Reports Fourth Quarter and Fiscal 2017 Financial Results
Novoheart Holdings Inc. today announced financial results for the three and twelve months ended June 30, 2017.
October 25, 2017
·
17 min read
Drug Development
Clearside Biomedical Announces Completion of Patient Enrollment in Phase II Clinical Trial of CLS-TA Used Together with Eylea in Patients with Diabetic Macular Edema
The trial has enrolled 71 patients who are naïve to pharmacologic treatment for DME.
October 25, 2017
·
4 min read
SYGNIS AG Announces the Launch of the Universal Lateral Flow Assay Kit and Associated Patent Filing
SYGNIS AG today announced the launch of its Universal Lateral Flow Assay (LFA) kit, the latest addition to its expanding range of lateral flow assay products and services which are being commercialized under the Innova Biosciences brand name.
October 25, 2017
·
3 min read
Business
MediWound Appoints Mr. Stephen T. Wills as Chairman to its Board of Directors
Mr. Wills was appointed to the Company’s Board as a Director in 2017.
October 25, 2017
·
5 min read
CorFlow Completes the First Close of the Seed+ Financing Round
CorFlow Therapeutics AG today announced that the company has completed the CHF 2.6M 1st close of its Seed+ financing round led by experienced private medical device investors who over the last decades have supported breakthrough interventional cardiology technologies.
October 25, 2017
·
2 min read
Nexstim Raises EUR 1.75 Million Via a Directed Issue of New Shares to London-Based Investor City Financial - Funds to be Used to Support Beginning The Commercialisation of Its NBT System
The new shares are expected to be registered with the Finnish Trade Register on or about 30 October 2017.
October 25, 2017
·
3 min read
Business
Ossur Hf: Q3 Results 2017
Sales in the third quarter of 2017 amounted to USD 139 million.
October 25, 2017
·
2 min read
Previous
6 of 22
Next